Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRETENSION bedtime versus morning aspirin study in essential hypertension
NL-OMON25788Phase 3Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aspirin in essential hypertension (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Plasma renin activity. Started Aug 2007; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NL-OMON25788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25788.